Having a role that gives you exposure to device development inside a pharma company can be illuminating. Historically, drug-makers (scientists) and device-makers (engineers) have not gotten along, and each typically has existed autonomously. But, with the explosion in biologics and biosimilars, the convergence of these two competencies has escalated.
